RUBOXISTAURIN HYDROCHLORIDE
- Product Name
- RUBOXISTAURIN HYDROCHLORIDE
- CAS No.
- 169939-93-9
- Chemical Name
- RUBOXISTAURIN HYDROCHLORIDE
- Synonyms
- LY333531 HCl;CAS:169939-93-9;Ruboxistaurin HCl;Ruboxistaurin(LY333531HCl);Ruboxistaurin Hydrochloride;Ruboxistaurin HCl(LY333531 );ruboxistaurin/LY 333531 hydrochloride;Ruboxistaurin hydrochloride (LY333531);LY 333531 hydrochloride - Ruboxistaurin;LY333531 Hydrochloride(Ruboxistaurin HCl)
- CBNumber
- CB9206452
- Molecular Formula
- C28H29ClN4O3
- Formula Weight
- 505.02
- MOL File
- 169939-93-9.mol
RUBOXISTAURIN HYDROCHLORIDE Property
- alpha
- D25 -28.7° (c = 1.0 in ethanol)
- storage temp.
- Inert atmosphere,Store in freezer, under -20°C
- solubility
- DMSO: soluble10mg/mL, clear
- form
- powder
- color
- orange-red
- InChIKey
- NYQIEYDJYFVLPO-QAYAHANANA-N
- SMILES
- O=C1NC(=O)C2C3=CN(CCO[C@]([H])(CN(C)C)CCN4C5=CC=CC=C5C(=C4)C1=2)C1=CC=CC=C31.Cl |&1:12,r|
Safety
- WGK Germany
- 3
N-Bromosuccinimide Price
- Product number
- SML0693
- Product name
- LY-333531 hydrochloride
- Purity
- ≥98% (HPLC)
- Packaging
- 1mg
- Price
- $148.2
- Updated
- 2025/07/31
- Product number
- 13964
- Product name
- LY333531 (hydrochloride)
- Purity
- ≥98%
- Packaging
- 1mg
- Price
- $106
- Updated
- 2024/03/01
- Product number
- 13964
- Product name
- LY333531 (hydrochloride)
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $311
- Updated
- 2024/03/01
- Product number
- R701525
- Product name
- RuboxistaurinHydrochloride
- Packaging
- 0.5mg
- Price
- $185
- Updated
- 2021/12/16
- Product number
- Axon2362
- Product name
- LY333531hydrochloride-Ruboxistaurin
- Purity
- 99%
- Packaging
- 5mg
- Price
- $214.5
- Updated
- 2021/12/16
RUBOXISTAURIN HYDROCHLORIDE Chemical Properties,Usage,Production
Description
LY333531 is an inhibitor of PKCβ (IC50s = 4.7 and 5.9 nM for PKCβ1 and PKCβ2, respectively). It is selective for PKCβ1 and PKCβ2 over PKCα, -γ, -δ, -ε, -ζ, and -η (IC50s = 360, 300, 250, >100,000, and 52 nM, respectively). LY333531 also inhibits glycogen synthase kinase 3β (GSK3β; IC50 = 39.4 nM). It inhibits neutrophil extracellular trap (NET) formation induced by phorbol 12-myristate 13-acetate (PMA; ) in primary human neutrophils when used at a concentration of 1 μM. LY333531 increases the mechanical nociceptive threshold in a rat model of diabetic hyperalgesia induced by streptozotocin (STZ; ).
Uses
A protein kinase C (PKC) β inhibitor, exhibits significant anti-angiogenic activity that reduces the response of vascular endothelial cells to stimulation by vascular endothelial growth factor (VEGF). It is used in treatment of diabetic microvascular comp
Uses
Ruboxistaurin is a protein kinase C (PKC) β inhibitor, exhibits significant anti-angiogenic activity that reduces the response of vascular endothelial cells to stimulation by vascular endothelial growth factor (VEGF). Ruboxistaurin is used in treatment of diabetic microvascular complications.
in vivo
Ruboxistaurin (1 mg/kg; 8 weeks) markedly reduces GEC apoptosis as well as swiprosin-1 upregulation, and ameliorates renal glomerular injury in the diabetic mice. Ruboxistaurin also potently attenuates the expression of PARP, cleaved-caspase9, cleaved-caspase3, and the Bax/Bcl-2 ratio, in diabetic mice[3]. Ruboxistaurin (0.1, 1.0, or 10.0 mg/kg; p.o.) dramatically reduces the number of leukocytes trapped in the retinal microcirculation of diabetic rats[4].
IC 50
PKCβI: 4.7 nM (IC50); PKCβII: 5.9 nM (IC50); PKCη: 52 nM (IC50); PKCδ: 250 nM (IC50); PKCγ: 300 nM (IC50); PKCα: 360 nM (IC50); PKCε: 600 nM (IC50)
References
[1] MICHAEL R. JIROUSEK. (S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and Related Analogues: Isozyme Selective Inhibitors of Protein Kinase Cβ[J]. Journal of Medicinal Chemistry, 1996, 39 14: 2664-2671. DOI: 10.1021/jm950588y
[2] PATRICIA A. VIGNAUX. Machine Learning for Discovery of GSK3β Inhibitors[J]. ACS Omega, 2020, 5 41: 26551-26561. DOI: 10.1021/acsomega.0c03302
[3] ROBERT D GRAY. Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps.[J]. Journal of Inflammation-London, 2013, 10 1: 12. DOI: 10.1186/1476-9255-10-12
[4] HYOH KIM. Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons.[J]. Diabetes, 2003, 52 8: 2102-2109. DOI: 10.2337/diabetes.52.8.2102
RUBOXISTAURIN HYDROCHLORIDE Preparation Products And Raw materials
Raw materials
Preparation Products
RUBOXISTAURIN HYDROCHLORIDE Suppliers
- Tel
- 15869524721
- 3525679403@qq.com
- Country
- China
- ProdList
- 4989
- Advantage
- 58
- Tel
- 021-50135380
- shchemsky@sina.com
- Country
- China
- ProdList
- 15402
- Advantage
- 60
- Tel
- 020-13556033878 2965585218 13556033878
- Fax
- 0086-0757-85406358
- chemcell@hotmail.com
- Country
- China
- ProdList
- 369
- Advantage
- 52
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Country
- China
- ProdList
- 4747
- Advantage
- 58
- Tel
- 021-58950125
- Fax
- (86) 21-58955996
- info@chemexpress.com
- Country
- China
- ProdList
- 7552
- Advantage
- 61
- Tel
- +86-021-58380978 13482386415
- Fax
- 021-58380978
- info@systeambc.com
- Country
- China
- ProdList
- 896
- Advantage
- 50
- Tel
- 025-66028182 18626450290
- yftan@aikonchem.com
- Country
- China
- ProdList
- 16679
- Advantage
- 50
- Tel
- Fax
- -
- eric_feng1954@126.com
- Country
- China
- ProdList
- 9248
- Advantage
- 55
- Tel
- 888-539-0666
- Fax
- 888-539-0666
- info@emmx.com
- Country
- United States
- ProdList
- 8447
- Advantage
- 60
- Tel
- +86-400-851-9921
- Fax
- +86-10-82826195
- sales@pharmacodia.com
- Country
- China
- ProdList
- 2317
- Advantage
- 55